Aldebaran Therapeutics
Aldebaran Therapeutics leverages human genetics and best-in-class antisense oligonucleotide (ASO) technology to deliver life-changing, precision ocular ASO medicines. Our focus on differentiated ASO technology, powered by Alloy Therapeutics' Genetic Medicines platform and novel AntiClastic™ ASO format, paves the way for a unique and rapid path to meaningful ocular solutions for patients.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
4
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Aldebaran Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
- AP
Andrew Peterson
Co-founder and Sab Member · General Business & Management
EmailPhone - CL
Carlos Loya
Founder & Board Member · General Business & Management
EmailPhone
Showing 2 of 2 verified contacts
Top roles at Aldebaran Therapeutics
2 distinct titles indexed · top 2 shown.
- 1co-founder and sab member
- 1founder & board member
Sign up to unlock all 2 contacts at Aldebaran Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Aldebaran Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.